LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance
- 26 September 2024
- journal article
- review article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (5) , 1-17
Abstract
Gastric cancer (GC) remains a major public health challenge worldwide. Long non-coding RNAs (lncRNAs) play important roles in the development, progression, and resistance to the treatment of GC, as shown by recent developments in molecular characterization. Still, an in-depth investigation of the lncRNA landscape in GC is absent. However, The objective of this systematic review is to evaluate our present understanding of the role that lncRNA dysregulation plays in the etiology of GC and treatment resistance, with a focus on the underlying mechanisms and clinical implications. Research that described the functions of lncRNA in angiogenesis, stemness, epigenetics, metastasis, apoptosis, development, and resistance to key treatments was given priority. In GC, it has been discovered that a large number of lncRNAs, including MALAT1, HOTAIR, H19, and ANRIL, are aberrantly expressed and are connected with disease-related outcomes. Through various methods such as chromatin remodeling, signal transduction pathways, and microRNA sponging, they modulate hallmark cancer capabilities. Through the activation of stemness programs, epithelial-mesenchymal transition (EMT), and survival signaling, LncRNAs also control resistance to immunotherapy, chemotherapy, and targeted therapies. By clarifying their molecular roles further, we may be able to identify new treatment targets and ways to overcome resistance. This article aims to explore the interplay between lncRNAs, and GC. Specifically, the focus is on understanding how lncRNAs contribute to the etiology of GC and influence treatment resistance in patients with this disease.Keywords
This publication has 93 references indexed in Scilit:
- Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor PrognosisDigestive Diseases and Sciences, 2015
- Long Noncoding RNA GAPLINC Regulates CD44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric CancerCancer Research, 2014
- The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancerMedical Oncology, 2014
- lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosisTumor Biology, 2014
- Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significancesTumor Biology, 2014
- nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancerOncotarget, 2014
- Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancerOncotarget, 2014
- Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stabilityThe FEBS Journal, 2014
- Function of lncRNAs and approaches to lncRNA-protein interactionsScience China Life Sciences, 2013
- Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cellsNucleic Acids Research, 2009